{"id":"W2107268345","doi":"10.1056/nejmoa062867","title":"Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia","year":2006,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3481,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital","funders":"Celgene; Pfizer; Kementerian Pendidikan Nasional; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Imatinib; Internal medicine; Cytarabine; Myeloid leukemia; Adverse effect; Imatinib mesylate; Philadelphia chromosome; Alpha interferon; Gastroenterology; Oncology; Surgery; Immunology; Interferon; Chromosomal translocation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}